The downregulation of UGCG ameliorated heart hypertrophy, as evidenced by reduced ventricular wall hypertrophy, lower heart weight-to-body weight ratios, decreased left ventricular weight-to-body weight ratios, reduced heart weight-to-tibial length ratios, and decreased cardiac fibrosis. The gene discussed is UGCG; the disease is cardiac hypertrophy.